Heart Test Laboratories, Inc.

NasdaqCM HSCS

Heart Test Laboratories, Inc. Free Cash Flow Yield on January 14, 2025: -131,616.33%

Heart Test Laboratories, Inc. Free Cash Flow Yield is -131,616.33% on January 14, 2025, a -216,981.20% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Heart Test Laboratories, Inc. 52-week high Free Cash Flow Yield is -45.08% on March 05, 2024, which is 99.97% above the current Free Cash Flow Yield.
Heart Test Laboratories, Inc. 52-week low Free Cash Flow Yield is -133,251.32% on January 13, 2025, which is -1.24% below the current Free Cash Flow Yield.
Heart Test Laboratories, Inc. average Free Cash Flow Yield for the last 52 weeks is -9,873.30%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NasdaqCM: HSCS

Heart Test Laboratories, Inc.

CEO	Mr. Andrew Simpson
IPO Date	June 16, 2022
Location	United States
Headquarters	550 Reserve Street
Employees	15
Sector	Health Care
Industries Medical Instruments Telehealth

Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Key trends

Past 5 years